Yuewu Chen
Haikou, 570103, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Elevated lipoprotein(a) and adverse outcomes in advanced coronary artery calcification: An intravascular ultrasound study.
Journal: International journal of cardiology. Cardiovascular risk and prevention
Published: January 21, 2026
Identification of TGF-β1 as a key regulator in DOX-induced cardiotoxicity.
Journal: Journal of cardiothoracic surgery
Published: January 01, 2026
Qishen Yiqi dropping pills improve cardiomyocyte hypertrophy via the lncRNA TINCR/miR-193b-3p/RORA axis.
Journal: Journal of thoracic disease
Published: July 26, 2022
Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats.
Journal: Journal of thoracic disease
Published: April 02, 2022
Role of IL-9, IL-2RA, and IL-2RB genetic polymorphisms in coronary heart disease.
Journal: Herz
Published: July 13, 2020
NT5C2 Gene Polymorphisms and the Risk of Coronary Heart Disease.
Journal: Public health genomics
Published: January 16, 2020
High cystatin C levels predict long-term mortality in patients with ST-segment elevation myocardial infarction undergoing late percutaneous coronary intervention: A retrospective study.
Journal: Clinical cardiology
Published: December 19, 2018
The long noncoding RNA XIST protects cardiomyocyte hypertrophy by targeting miR-330-3p.
Journal: Biochemical and biophysical research communications
Published: September 15, 2018
Increased Cystatin C Level in ST-Elevation Myocardial Infarction Predisposes the Prognosis of Angioplasty.
Journal: The American journal of the medical sciences
Published: August 26, 2017
The prognostic value of autoantibodies against β1-adrenoceptor and cardiac troponin-I for clinical outcomes in STEMI.
Journal: Journal of cardiovascular medicine (Hagerstown, Md.)
Published: August 11, 2015
Last Updated: 09/26/2026